Table 2.
3-years costs (present value calculated in the incidence year)a | Annual attributable cost estimates (not discounted)b | |||
---|---|---|---|---|
Year 0 (incidence year) | Year 1 after the bleeding event | Year 2 after the bleeding event | ||
Direct costs | ||||
Healthcare | 18,061 | 16,309 | 2985 | −427 |
Inpatient hospital care | 18,078 | 16,341*** | 3094*** | −557 |
Outpatient hospital care | −49 | 132 | −192 | 2 |
Private practice health prof. | 73 | −69*** | 68** | 86** |
Prescribed medicine | −42 | −96*** | 16 | 41 |
Social care services | 7524 | 1546 | 3313 | 3345 |
Home help | 3929 | 419** | 1844*** | 2048*** |
Nursing home | 3595 | 1127*** | 1469*** | 1297*** |
Indirect costs | ||||
Productivity loss | 2042 | 194 | 624** | 1438*** |
Direct and indirect costs | 27,627 | 18,049 | 6922 | 4356 |
a3-years costs (present value) are equal to the sum of the costs in year 0 and the discounted value of the costs in years 1 and 2 after the bleeding event
bT-tests were used to investigate whether the annual attributable cost estimates related to hospital care, visits to GPs and other health professionals in the primary care setting, prescribed medicine, home help, nursing home and productivity loss were significantly different from zero (H0: μ = 0 against the hypothesis H1: μ ≠ 0.). Asterisks indicate that the null-hypothesis was rejected (*p < 0.05, **p < 0.01, ***p < 0.001)